Cargando…

Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status

OBJECTIVES: To investigate whether MRI-based measurements of fibro-glandular tissue volume, breast density (MRBD), and background parenchymal enhancement (BPE) could be used to stratify two cohorts of healthy women: BRCA carriers and women at population risk of breast cancer. METHODS: Pre-menopausal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goodburn, Rosie, Kousi, Evanthia, Sanders, Clarrissa, Macdonald, Alison, Scurr, Erica, Bunce, Catey, Khabra, Komel, Reddy, Mamatha, Wilkinson, Louise, O’Flynn, Elizabeth, Allen, Steven, Schmidt, Maria Angélica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Breast
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415521/ https://www.ncbi.nlm.nih.gov/pubmed/37017702 http://dx.doi.org/10.1007/s00330-023-09592-2

Ejemplares similares

Correction: Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Background parenchymal enhancement in contrast-enhanced MR imaging suggests systemic effects of intrauterine contraceptive devices
por: Huck, Luisa Charlotte, et al.
Publicado: (2022)

Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement
por: Kim, Soo-Yeon, et al.
Publicado: (2020)

The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
por: Hellgren, Roxanna, et al.
Publicado: (2020)

An Innovative Autologous Breast Reconstruction Option: Musculo-derma-glandular, Axio-perforator, Bipedicled Flap
por: Kalender, Vagif, et al.
Publicado: (2020)

Simultaneous Breast and Nipple–Areolar Reconstruction Using Musculo-derma-glandular, Axio-perforator, Bipedicled Flap
por: Kalender, Vagif, et al.
Publicado: (2021)

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008)

Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index
por: Ragusi, Max A. A., et al.
Publicado: (2020)

Evaluation of breast parenchymal density with QUANTRA software
por: Pahwa, Shivani, et al.
Publicado: (2015)

Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients
por: van der Velden, Bas H. M., et al.
Publicado: (2018)

Improved characterization of sub-centimeter enhancing breast masses on MRI with radiomics and machine learning in BRCA mutation carriers
por: Lo Gullo, Roberto, et al.
Publicado: (2020)

Glandular Tissue Component on Breast Ultrasound in Dense Breasts: A New Imaging Biomarker for Breast Cancer Risk
por: Lee, Su Hyun, et al.
Publicado: (2022)

Inter- and intra-observer agreement on evaluating the presence of residual glandular tissue with magnetic resonance tomography following prophylactic mastectomy
por: Skoglund, Märta A, et al.
Publicado: (2021)

Prolonged recombinant pregnancy hormone use in BRCA1 and BRCA2 mutation carriers
por: Depypere, Herman, et al.
Publicado: (2021)

Background enhancement in contrast-enhanced spectral mammography (CESM): are there qualitative and quantitative differences between imaging systems?
por: Wessling, Daniel, et al.
Publicado: (2022)

Comparison of Immediate versus Delayed DIEP Flap Reconstruction in Women Who Require Postmastectomy Radiotherapy
por: O’Connell, Rachel L., et al.
Publicado: (2018)

Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer
por: Savill, Kristin M Zimmerman, et al.
Publicado: (2023)

Exploiting the Dixon Method for a Robust Breast and Fibro-Glandular Tissue Segmentation in Breast MRI
por: Samperna, Riccardo, et al.
Publicado: (2022)

Quantitative evaluation of contrast agent uptake in standard fat‐suppressed dynamic contrast‐enhanced MRI examinations of the breast
por: Kousi, Evanthia, et al.
Publicado: (2017)

Trans-nipple removal of fibro-glandular tissue in gynaecomastia surgery without additional scars: An innovative approach
por: Mishra, R. K.
Publicado: (2014)

Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies
por: Morganti, Stefania, et al.
Publicado: (2023)

The Ergonomic FALD Flap for One-stage Total Breast Reconstruction
por: Longo, Benedetto, et al.
Publicado: (2023)

Background parenchymal enhancement in preoperative breast MRI
por: Kohara, Satoko, et al.
Publicado: (2015)

Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging
por: Ko, Kyung Hee, et al.
Publicado: (2017)

Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial
por: Hurvitz, Sara A., et al.
Publicado: (2019)

Bilateral Triple Negative Invasive Ductal Breast Carcinoma in a BRCA1 Mutation Carrier with Discrepant Pathologic Response to Neoadjuvant Chemotherapy
Publicado: (2020)

Clinicopathological and ultrasound characteristics of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ikejima, Kengo, et al.
Publicado: (2023)

Prophylactic Mastectomy in BRCA1/2 Mutation Carriers and Women at Risk of Hereditary Breast Cancer: Long-Term Experiences at the Rotterdam Family Cancer Clinic
por: Heemskerk-Gerritsen, Bernadette A. M., et al.
Publicado: (2007)

Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study
por: Litton, Jennifer K, et al.
Publicado: (2023)

MRI Texture Analysis of Background Parenchymal Enhancement of the Breast
por: Amano, Yasuo, et al.
Publicado: (2017)

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors
por: Thanopoulou, Eirini, et al.
Publicado: (2014)

Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Quality assurance in MRI breast screening: comparing signal-to-noise ratio in dynamic contrast-enhanced imaging protocols
por: Kousi, Evanthia, et al.
Publicado: (2016)

Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions
por: Veltman, J., et al.
Publicado: (2008)

What parameters affect pain in core biopsy?
por: Zografos, George C., et al.
Publicado: (2008)

Value of tissue harmonic imaging (THI) and contrast harmonic imaging (CHI) in detection and characterisation of breast tumours
por: Clevert, D.- A., et al.
Publicado: (2006)

Computer-aided detection in breast MRI: a systematic review and meta-analysis
por: Dorrius, Monique D., et al.
Publicado: (2011)

Using computer-aided detection in mammography as a decision support
por: Samulski, Maurice, et al.
Publicado: (2010)

Stereotactic large-core needle breast biopsy: analysis of pain and discomfort related to the biopsy procedure
por: Hemmer, Judith M., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_1re8i5ljp93450q4qptpq4sfpe